UTMD (Utah Medical Products Inc) Stock Analysis - News
Utah Medical Products Inc (UTMD) is a publicly traded Healthcare sector company. As of May 21, 2026, UTMD trades at $64.17 with a market cap of $203.78M and a P/E ratio of 19.03. UTMD moved +0.00% today. Year to date, UTMD is +11.41%; over the trailing twelve months it is +18.35%. Its 52-week range spans $51.26 to $71.81. Rallies surfaces UTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in UTMD news today?
Utah Medical’s Q1 Revenue Falls 10.2% to $8.7M, EPS at $0.82: Utah Medical’s first-quarter revenue dropped 10.2% year-over-year to $8.7 million, while gross profit declined 4.6% to $5.28 million, lifting gross margin to 60.6% from 57.0%. Operating income fell 18.7% to $2.57 million, net income decreased 14.4% to $2.6 million, and EPS slid 11.0% to $0.82 after repurchasing 96,864 shares.
RICHINS PAUL O sold 700 (~$65.43K) on May 18, 2023.
RICHINS PAUL O sold 449 (~$40.77K) on Nov 18, 2022.
RICHINS PAUL O sold 161 (~$14.49K) on Nov 17, 2022.
UTMD Analyst Consensus
UTMD analyst coverage data. Average price target: $0.00.
Common questions about UTMD
What changed in UTMD news today?
Utah Medical’s Q1 Revenue Falls 10.2% to $8.7M, EPS at $0.82: Utah Medical’s first-quarter revenue dropped 10.2% year-over-year to $8.7 million, while gross profit declined 4.6% to $5.28 million, lifting gross margin to 60.6% from 57.0%. Operating income fell 18.7% to $2.57 million, net income decreased 14.4% to $2.6 million, and EPS slid 11.0% to $0.82 after repurchasing 96,864 shares.
Does Rallies summarize UTMD news?
Yes. Rallies summarizes UTMD news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is UTMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UTMD. It does not provide personalized investment advice.
